Narrative review highlights metabolomics applications in acute respiratory distress syndrome, suggesting new pathophysiological insights.
Acute respiratory distress syndrome (ARDS) is a clinical condition characterized by damage and inflammation of the alveolar-capillary membrane, which is associated with high incidence and mortality rates. Metabolomics, a significant field of systematic biology, provides a novel perspective for understanding the pathophysiological mechanisms underlying ARDS by analyzing small molecule metabolites in biological samples. This narrative review explores the application of metabolomics in ARDS.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: